MIF and neoplasm: In conclusion, our newly developed allosteric MIF tautomerase inhibitor MN123 and MIF‐PROTACs can enhance ferroptotic cell death and persistently inhibit tumor cell proliferation in combination with a non‐toxic dose of GPX4 inhibitor RSL3.